(Q46849985)

English

Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Cindy Lamendola

5

object named as

Cindy Lamendola

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

7

object named as

Gerald M Reaven

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

author name string

Fahim Abbasi

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

Sang-Ah Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

James W Chu

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

Theodore P Ciaraldi

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

Tracey McLaughlin

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

Peter D Reaven

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

290

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

R139-44

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

Discrimination between obesity and insulin resistance in the relationship with adiponectin

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Regulation of adipocytokines and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Improved beta-cell function after standardized weight reduction in severely obese subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Adiponectin is not altered with exercise training despite enhanced insulin action

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Roles of insulin resistance and obesity in regulation of plasma insulin concentrations.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

ACRP30, a new hormone controlling fat and glucose metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00287.2005

21 January 2018

Identifiers

10.1152/AJPREGU.00287.2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16352858

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46849985&oldid=2134700277"